Abstract
Our understanding of the efficacy and safety of ustekinumab for the treatment of pediatric plaque psoriasis is limited to two phase 3 clinical trials.1,2 To evaluate the real-world experience of this biologic in children and adolescents, we conducted a retrospective chart review at a community dermatology practice in Calgary, Canada.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
